Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionSound View Wealth Advisors Group, LLC
Latest Disclosed Ownership3,863 shares
Latest Disclosed Value $ 1,724,886
Sound View Wealth Advisors Group, LLC reports 0.18% decrease in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On May 6, 2026 - Sound View Wealth Advisors Group, LLC filed a 13F-HR form disclosing ownership of 3,863 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $1,724,984 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 8, 2026 disclosing 3,870 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -0.18% during the quarter. The current value of the position is $1,726,104 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,863 -7 -0.18 1,725 -1.71 0.1173
2026-01-08 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,870 241 6.64 1,754 23.43 0.1177
2025-11-10 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,629 5 0.14 1,421 -11.90 0.0977
2025-08-07 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,624 94 2.66 1,613 -5.73 0.1192
2025-05-08 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,530 94 2.74 1,711 23.72 0.1404
2025-02-07 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,436 136 4.12 1,384 -9.84 0.1114
2024-11-12 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,300 320 10.74 1,535 9.89 0.1253
2024-08-05 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,980 -51 -1.68 1,397 10.27 0.1440
2024-05-09 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,031 -182 -5.66 1,267 -3.14 0.1350
2024-02-08 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,213 -74 -2.25 1,307 14.35 0.1442
2023-11-07 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,287 226 7.38 1,143 6.13 0.1422
2023-08-08 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,061 -263 -7.91 1,077 2.87 0.1412
2023-05-12 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,324 111 3.45 1,047 -19.89 0.1437
2024-02-13 2022-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 3,213 931 40.80 1,307 97.73 0.1442
2023-02-08 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,236 -46 646 0.1365
2022-11-08 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,282 38 1.69 661 4.59 0.1482
2022-08-05 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,244 -757 -25.22 632 -19.28 0.1323
2022-05-11 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,001 -49 -1.61 783 16.87 0.1489
2022-01-20 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,050 194 6.79 670 29.34 0.1266
2021-10-21 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,856 454 18.90 518 7.02 0.1082
2021-07-21 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,402 1,096 83.92 484 72.24 0.1017
2021-04-28 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,306 160 13.96 281 3.69 0.0654
2021-02-02 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,146 134 13.24 271 -1.45 0.0662
2020-11-09 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,012 11 1.10 275 -5.50 0.0724
2020-08-07 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,001 94 10.36 291 34.72 0.0820
2020-05-12 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 907 907 216 0.0746
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.